We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$53.6B
AUM Growth
+$2.66B
(+5.2%)
Cap. Flow
+$86.8M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
37.17%
Holding
821
New
56
Increased
227
Reduced
258
Closed
253
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$86.2M |
| 2 |
Alcon
ALC
|
+$81.8M |
| 3 |
NVIDIA
NVDA
|
+$76M |
| 4 |
Corning
GLW
|
+$50.4M |
| 5 |
UnitedHealth
UNH
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$67.4M |
| 2 |
Factset
FDS
|
+$62M |
| 3 |
Euronet Worldwide
EEFT
|
+$42.3M |
| 4 |
Bank of America Series L
BAC.PRL
|
+$39.5M |
| 5 |
OPLN
Openlane
OPLN
|
+$31.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 17.74% |
| 3 | Financials | 11.65% |
| 4 | Healthcare | 11.2% |
| 5 | Communication Services | 10.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
451
AES
AES
$10.5B
| $1.31M | ﹤0.01% |
78,301
-64,641
| -45% | -$1.09M |
|
452
Morgan Stanley
MS
$340B
| $1.3M | ﹤0.01% |
29,687
+22,175
| +295% | +$989K |
|
453
Medtronic
MDT
$112B
| $1.12M | ﹤0.01% |
11,528
+10,107
| +711% | +$923K |
|
454
iShares MSCI Japan ETF
EWJ
$23B
| $1.08M | ﹤0.01% |
19,808
-6,788
| -26% | -$369K |
|
455
Southern Company
SO
$107B
| $948K | ﹤0.01% |
+17,147
| New | +$918K |
|
456
Exelon
EXC
$47B
| $930K | ﹤0.01% |
27,200
+26,631
| +4,680% | +$940K |
|
457
General Dynamics
GD
$106B
| $692K | ﹤0.01% |
+3,808
| New | +$656K |
|
458
Applied Materials
AMAT
$428B
| $663K | ﹤0.01% |
+14,761
| New | +$621K |
|
459
PepsiCo
PEP
$190B
| $643K | ﹤0.01% |
4,902
-1,655
| -25% | -$212K |
|
460
General Mills
GIS
$19.7B
| $641K | ﹤0.01% |
+12,201
| New | +$630K |
|
|
IPG
461
DELISTED
Interpublic Group of Companies
IPG
| $641K | ﹤0.01% |
28,374
-82,756
| -74% | -$1.84M |
|
462
IBM
IBM
$224B
| $631K | ﹤0.01% |
+4,790
| New | +$629K |
|
463
Vanguard Morningstar Growth ETF
VUG
$231B
| $623K | ﹤0.01% |
22,872
+22,710
| +14,019% | +$607K |
|
|
CBB.PRB
464
DELISTED
Cincinnati Bell Inc. DEP SHS
CBB.PRB
| $591K | ﹤0.01% |
4,625
| – | – |
|
465
State Street SPDR Nuveen ICE High Yield Municipal Bond ETF
HYMB
$3.19B
| $585K | ﹤0.01% |
20,000
| – | – |
|
466
Best Buy
BBY
$17.3B
| $527K | ﹤0.01% |
7,568
-28,078
| -79% | -$1.96M |
|
467
EPR Properties
EPR
$4.77B
| $516K | ﹤0.01% |
6,917
-1,908
| -22% | -$149K |
|
468
State Street SPDR S&P 500 ETF Trust
SPY
$823B
| $515K | ﹤0.01% |
1,757
+1,482
| +539% | +$427K |
|
469
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$12B
| $512K | ﹤0.01% |
+14,760
| New | +$502K |
|
|
UN
470
DELISTED
Unilever NV New York Registry Shares
UN
| $509K | ﹤0.01% |
8,384
+417
| +5% | +$25K |
|
471
Diageo
DEO
$53.6B
| $362K | ﹤0.01% |
2,103
+108
| +5% | +$18.2K |
|
472
Allison Transmission
ALSN
$9.82B
| $357K | ﹤0.01% |
7,697
-43,642
| -85% | -$1.98M |
|
473
Fidelity National Information Services
FIS
$22.1B
| $337K | ﹤0.01% |
2,751
-16,131
| -85% | -$1.89M |
|
474
First Hawaiian
FHB
$3.35B
| $336K | ﹤0.01% |
12,995
-78,877
| -86% | -$2.09M |
|
475
National Fuel Gas
NFG
$7.65B
| $336K | ﹤0.01% |
6,374
-12,359
| -66% | -$704K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q2 2019 Portfolio in Review
As of Q2 2019, Loomis, Sayles & Company held 821 positions worth $53.6B, up 5.2% from $50.9B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Loomis, Sayles & Company's Q2 2019 filing shows 56 new, 227 increased, 258 reduced and 253 closed positions. Its largest new stake was Alcon: 1,393,674 shares worth $86.5M. The largest sale was Novartis, an estimated $67.4M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- Loomis, Sayles & Company's largest Q2 2019 buy was Alcon: 1,393,674 shares worth $86.5M.
- Loomis, Sayles & Company added most to Bristol-Myers Squibb in Q2 2019, an estimated $86.2M increase.
- Loomis, Sayles & Company's biggest Q2 2019 reduction was Novartis, cutting an estimated $67.4M.
- Loomis, Sayles & Company fully exited RingCentral in Q2 2019, selling an estimated $30.4M.
- Loomis, Sayles & Company's ten largest holdings make up 37% of its $53.6B portfolio in Q2 2019.
- Loomis, Sayles & Company opened 56 new positions and closed 253 in Q2 2019.
- Loomis, Sayles & Company's portfolio value rose 5.2% quarter-over-quarter to $53.6B.
Based on Loomis, Sayles & Company's 13F filing for Q2 2019, filed 14 Aug 2019.